The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Primary analysis of the randomized phase II trial of bortezomib, lenalidomide, dexamthasone with/without elotuzumab for newly diagnosed, high-risk multiple myeloma (SWOG-1211).
 
Saad Zafar Usmani
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Seagen; Skyline Diagnostics; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen Oncology; Takeda
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; Janssen Oncology; Pharmacyclics; Sanofi; Seagen
 
Sikander Ailawadhi
Consulting or Advisory Role - Amgen; Celgene; Janssen Biotech; Takeda
Research Funding - Celgene (Inst); Cellectar (Inst); Janssen Biotech (Inst); Pharmacyclics (Inst); Phosplatin Therapeutics (Inst)
Travel, Accommodations, Expenses - Amgen; Novartis; Takeda
 
Rachael Sexton
No Relationships to Disclose
 
Antje Hoering
No Relationships to Disclose
 
Brea Lipe
Consulting or Advisory Role - Amgen; celgene; GlaxoSmithKline
Research Funding - Amgen (Inst); Celgene (Inst); cellectar (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Seagen (Inst)
 
Sandi Hita
No Relationships to Disclose
 
Brian G. Durie
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda
 
Jeffrey A. Zonder
Consulting or Advisory Role - Alnylam; Amgen; Bristol-Myers Squibb; Caelum Biosciences; Celgene; Intellia Therapeutics; Janssen; Oncotherapeutics; Prothena; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst)
 
Madhav V. Dhodapkar
Consulting or Advisory Role - Amgen; Celgene; Janssen Oncology; Kite, a Gilead company; lava therapeutics; Roche/Genentech
 
Natalie Scott Callander
Research Funding - Cellectar
 
S. Vincent Rajkumar
Patents, Royalties, Other Intellectual Property - Authorship Royalties from Up To Date
 
Peter Michael Voorhees
Consulting or Advisory Role - Adaptive Biotechnologies; Celgene; GlaxoSmithKline; Janssen; Novartis; Oncopeptides; TeneoBio
 
Paul G. Richardson
Consulting or Advisory Role - Celgene; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Oncopeptides; Sanofi; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Oncopeptides (Inst); Takeda (Inst)
 
Robert Z. Orlowski
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Kite, a Gilead company; Sanofi; Takeda
Research Funding - Amgen; BioTheryX; Spectrum Pharmaceuticals